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Background & objectives: Definitions of in vitro resistance to  rifampicin in. strains of Mycobacterium 
tuberculosis by different methods have not been consistent, leading to variations in the interpretation 
a n d  validity of results. This  study compared three methods of defining in vitro resistance to 
rifampicin. 
Methods: (i) A total of 598 clinical isolates of M. tuberculosis were concurrently compared by the 
minimal inhibitory concentration (MIC) and the proportion method on Lowenstein-Jensen medium; 
(ii) 54 strains tested by the MIC method were retested by the  proportion method and  the BACTEC 
radiometric method; and  (iii) 72 strains which yielded a n  M I C  of 64 mg/l by the MIC method were 
retested by the same method. 
Results: Out  of 598 cultures tested by the MIC and the proportion methods, identical classification as 
susceptible o r  resistant was observed in 99.7 per  cent. A 100 per  cent agreement was observed when 
54 strains were tested by the MIC, proportion and  BACTEC radiometric methods. When 72 strains 
with a n  MIC of 64 mg/l were retested by the same method, 61 (85%) yielded a lower MIC, 9 (12%) 
gave the same M I C  while 2 (3%) yielded a higher MIC of 128 mg/l, reflecting perhaps the inherent 
limitations of the variations in the inoculum size. 
Interpretation & conclusion: All 3 definitions of resistance, viz., an M I C  of 128 mg/l, a proportion of 
I per cent o r  more on 40 mg/l by the proportion method, both on L-J medium and a growth of 1 per  
cent o r  more on 2 mg/l by the radiometric method were found to be  equally satisfactory. 
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The standardization of  drug susceptibility 
determinations has become important to formulate 
treatment policies for patients with drug resistant 
tuberculosis, especially those with multi-drug 
resistance (MDR-TB). A lack of standardization in 
the methodology and definitions of resistance may 
cause errors in the interpretation and validity of the 
tests and when results from different studies are 
compared. Although the definition of resistance to 
isoniazid has been uniform in most of the studies 
undertaken world-wide, it has not been so in the 
case of rifampicin resistance. Thus, while the 
Tuberculosis Research Centre, Chennai has been 
consistently using a minimal inhibitory concentration 
(MIC) of 128 mg/l or more on Lowenstein-Jensen 
(L-J) medium to define resistance to rifampicin', 
British workers have used MICs of both 64 and 128 
mg/l as indicative of The World Health 
Organization (WHO) and the International Union 
Against Tuberculosis and Lung Diseases (IUATLD) 
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recommend a growth of 1 per cent or more on a 
concentration of 40 mg/l by the proportion method to 
indicate resistance4,5. For the BACTEC radiometric 
method a concentration of 2 mg/l has been used to 
define resistance to rifampicin6. 
Hence, a comparison of definitions of resistance 
to rifampicin by the MIC and proportion methods on 
L-J medium as well as by the radiometric method 
was undertaken, the results of which are presented. 
Material & Methods 
Strains: ( i )  A total of 598 consecutive clinical 
isolates . of Mycobacterium tuberculosis were 
concurrently tested by the MIC and the proportion 
methods on L-J medium. 
( i i )  Fifty four strains of M. tuberculosis, 
comprising 35 strains which were sensitive and 19 
strains which were resistant to rifampicin by the 
MIC method, were retested by the proportion and 
the BACTEC radiometric methods. 
(iii) Seventy two clinical isolates, from patients 
admitted to controlled clinical trials at this Centre, 
which had shown a MIC of 64 mg/l by the MIC 
method, were retested by the same method to 
observe the consistency of the results obtained. 
All the above investigations were undertaken 
during the period 1998-99. 
Methods: L-J medium, without potato starch7, 
prepared in the laboratory and BACTEC 12B 
medium obtained from Becton Dickinson Diagnostic 
Systems, USA were used for the study. 
Susceptibility testing: For the MIC method, a 3 mm 
loopful of the bacterial suspension containing 
approximately 4 mg/ml was used to inoculate drug- 
free and drug-containing slopes (32, 64 and 128 
mg/l). The standard strain, M. tuberculosis H37 Rv 
was included in every batch of tests as a check on 
the inoculum size as well as the drug concentrations 
in the medium. The slopes were incubated at 37oC 
and read at the end of 28 days. The lowest drug 
concentration which inhibited growth (defined as 20 
colonies) was taken as the MIC8. 
The proportion tests were set up on a single 
concentration of 40 mg/l, using the neat and three 
serial ten-fold dilutions of the inoculum as 
recommended by Canetti and others4. The standard 
strain H37, Rv was tested with every new batch of 
medium. The tests were read at 42 days. The 
number of bacilli growing on the drug-containing 
slope was expressed as a proportion of the number 
of colonies on the drug-free slope. 
The BACTEC radiometric method was 
performed as described earlier9. 
Definition of resistance: For the MIC method, a 
MIC of 128 mg/l or more was interpreted as 
indicative of resistance. For the proportion method, 
a growth of 1 per cent or more on the drug-containing 
slope (40 mg/l) when compared to the growth on the 
control slope was interpreted as resistant. In the 
BACTEC radiometric method, growth of a proportion 
of 1 per cent or more in the drug-containing vial 
(2 mg/l) indicated resistance. Thus, a strain was 
reported as resistant when the difference in growth 
index ( D GI) between two consecutive daily readings 
in the drug-containing vial (inoculated with the neat 
suspension) was more than the D GI in the drug-free 
vial (inoculated with a 1: 100 diluted inoculum) during 
the same period. 
Statistical methods: The significance of data was 
analysed using the Chi-square test. 
Results 
Of the 598 clinical isolates tested by the MIC and 
proportion methods, 572 (95.6%) were classified as 
sensitive by the MIC method while 26 (4.3%) were 
resistant (Table I). By the proportion method, 570 
(95.3%) were classified as sensitive and 28 (4.7%) 
as resistant. Thus, the agreement between the two 
methods was 99.7 per cent. Two strains sensitive by 
the MIC method were observed as resistant by the 
proportion method. The difference in classification 
(0 vs 2) was not statistically significant. 
When 54 strains tested by the MIC method were 
retested by the proportion and the BACTEC 
radiometric methods, there was a 100 per cent 
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agreement in the classification as sensitive or 
resistant by both methods (Table 11). 
Amalgamating Tables 1 and-11, out of 652 strains 
tested by the MIC and the proportion methods, as 
many as 650 (99.7%) yielded an identical 
classification; an excellent agreement. When the 72 
strains with an MIC of 64 mg/l in the first test were 
retested, as many as 61(85%) showed an MIC of 32 
or less, 2 strains (3%) were resistant (MIC 128) 
while 9 strains (12%) showed the same MIC of 
64 mg/l (results not tabulated). 
Discussion 
Standardization of definitions of resistance to anti- 
tuberculosis drugs helps in the comparison of results 
between laboratories and also between various 
methods. A uniform definition for resistance is not 
being employed by laboratories reporting drug 
susceptibility results for rifampicin by the MIC 
method. This method is known to be affected by 
the inoculum size based both on the bacterial content 
in the suspension as well as the volume used to 
inoculate the slopes10. 
Table 1. Rifampicin susceptibility test results clinical isolates 
o f  M.tuberculosis by the MIC and proportion methods 
MIC Proportion method 
method Total 
Sensitive Resistant 
Sensitive 570 
Resistant 0 
Total 570l 
2 572 
26 26 
28 598 
Table II.  Comparison of rifampicin susceptibility test results 
by the proportion method and BACTEC radiometric method 
with the MIC method in  strains of M.tuberculosis 
method - - M IC Proportion method BACTEC method Total 
Sensitive Resistant Sensitive Resistant 
Sensitive 35 0 35 0 35 
Resistant 0 19 0 19 19 
Total 35 19 35 19 5 4  
The Tuberculosis Research Centre (TRC), 
Chennai, India, has been using the definition of an 
MIC of 128 mg/l or more on L-J medium for defining 
resistance to rifampicin'. This definition was arrived 
at by correlating the number of unfavourable 
responses among patients following treatment with 
rifampicin-containing regimens using the MICs of 
128 and 64 mg/l as used by British  workers2,3. Thus, 
two major chemotherapy studies were undertaken at 
this Center involving 2161 patients11,12. Of these, 
1692 had organisms sensitive to all drugs initially and 
78 had organisms with rifampicin MIC of 64 mg/l, 
none of whom had an unfavourable response. On 
the other hand, of the 71 patients (who were also 
resistant to isoniazid) with pretreatment rifampicin 
MIC of 128 mg/l or more, 66 (93%) had an 
unfavourable response, a highly significant difference 
( P < 0 . 0 0  1)  (Tuberculosis Research Centre, 
unpublished observations). Further, our definition has 
correlated well with the BACTEC definition in a 
series of ongoing external quality assessment studies 
being undertaken at this Centre by the WHO supra- 
regional laboratories in Australia and Belgium. Out 
of 77 strains tested for susceptibility to rifampicin till 
date, identical classification as sensitive or resistant 
was obtained in 76 (98.7%) strains (unpublished 
data). Further, this Centre has also been regularly 
implementing internal quality control in drug 
susceptibility tests using a panel of 10 standard 
strains, comprising known resistant as well as 
sensitive strains. The rifampicin-resistant strain was 
tested on 181 occasions and the sensitive strain on 
149 occasions over a two year period. Correct 
classifications were obtained on 180 occasions 
(99.4%) for the resistant strain and on 148 occasions 
for the sensitive strain (99.3%). Thus, the 
reproducibility of results has been excellent over the 
two year period. 
Out of the 652 isolates tested by the MIC method 
and the proportion method in the present study, 
,agreement in results was observed in 650 (99.7%) 
strains. In 54 strains compared by the MIC method 
and the radiometric method, 100 per cent agreement 
in results was obtained. An earlier study from this 
Centre, on 78 strains comparing the radiometric 
method with the MIC method, yielded 99 per cent 
agreement between the two methods9. This shows 
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that the definition of 128 mg/l for resistance as used 
in the MIC method is valid. 
It is known that the development of resistance in 
mycobacteria to rifampicin is a single-step process 
and that there is no borderline or doubtful resistance 
to rifampicin unlike in the case of drugs like 
streptomycin or isoniazid13. Thus, most of the 
cultures are either fully sensitive (MIC 32 or less) or 
resistant (MIC 128 or more) and strains with a MIC 
64 mg/l are rare. An analysis of over 8000 strains 
tested before treatment at this Centre in a 10-year 
period from more than 4000 patients showed that 
the proportion of strains with a MIC of 64 mg/l was 
of the order of 1.6 per cent (unpublished 
observations). When a sample of these strains was 
retested in the present study, 85 per cent had a MIC 
of 32 mg/l. It is likely that growth on 32 mg/l, 
resulting in a MIC of 64 mg/l, could have been due 
perhaps to a heavier inoculum, which is an inherent 
limitation of the MIC method. 
It is, therefore, recommended that the proportion 
test, being more precise, and as recommended by 
the WHO and IUATLD4,5, may be employed using 
the criterion of 1 per cent or more growth on a 
single concentration of 40 mg/l as reported in this 
study. If, for any reason, only the MIC method is 
employed due to non-availability of technical 
infrastructure, a MIC of 128 mg/l or more would be 
the best definition of resistance to rifampicin. A 
further advantage of the MIC method is that it is the 
least expensive and far less complicated than the 
other method. The BACTEC radiometric method 
yields results within a few days, but requires 
considerable technical experience and involves high 
costs, both initial and recurring9. 
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